Estimated geographical and temporal distribution of lung-cancer incidence varied across the four main subtypes worldwide. Our ...

[41] The same group also examined 129 lung squamous cell carcinomas using 22,000 ... to patients in their testing cohort with stage IA lung cancer, as well as when applied to patients in their ...

A global analysis of lung cancer incidence has uncovered significant geographical and temporal variations in histological ...

Squamous cell carcinoma is a cancer that starts in squamous cells ... It can also be used after surgery if it was not possible to remove all the cancerous tissue. In late stage lung cancer, ...

THE proportion of people diagnosed with lung cancer who’ve never smoked is increasing, the World Health Organization (WHO) ...

A recent study published in The Lancet Respiratory Medicine revealed an increase in lung cancer cases among non-smokers, ...

Serplulimab is the world’s first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC; Serplulimab is the first and only anti-PD-1 mAb approved in th ...

Non-small-cell lung cancer ... are characterized by cancer cells that grow and spread in different ways. The three most common forms of NSCLC are adenocarcinoma, squamous cell carcinoma and ...

Following an update from the company that market the drug, NICE will not be progressing with the scoping exercise at this stage. The consultation ... maintenance treatment of advanced squamous ...